<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Unstable carotid plaques cause <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral emboli</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Leptin promotes <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and vessel wall remodeling </plain></SENT>
<SENT sid="2" pm="."><plain>We hypothesized that carotid atherosclerotic lesion instability is associated with local leptin synthesis </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS AND RESULTS: Carotid endarterectomy plaques from symptomatic (n=40) and asymptomatic patients with progressive stenosis (n=38) were analyzed for local expression of leptin, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor (TNF)-α, and plasminogen activator inhibitor type 1 </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> lesions exhibited advanced <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> inclusive of thick- and thin-cap fibroatheromas or lesion rupture </plain></SENT>
<SENT sid="5" pm="."><plain>Symptomatic lesions exhibited more plaque ruptures and macrophage infiltration (P=0.001 and P=0.05, respectively) </plain></SENT>
<SENT sid="6" pm="."><plain>Symptomatic plaques showed preferential leptin, TNF-α, and plasminogen activator inhibitor type 1 transcript (P=0.03, P=0.04, and P=0.05, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Leptin <z:chebi fb="2" ids="33699">mRNA</z:chebi> and antigen in macrophages and smooth muscle cells were confirmed by in situ hybridization and immunohistochemistry </plain></SENT>
<SENT sid="8" pm="."><plain>Plasma leptin levels were not significantly different between groups (P=1.0), whereas TNF-α was significantly increased in symptomatic patients (P=0.006) </plain></SENT>
<SENT sid="9" pm="."><plain>Human aortic smooth muscle cell culture stimulated by TNF-α, <z:chebi fb="0" ids="16412">lipopolysaccharide</z:chebi>, or lipoteichoic acid revealed 6-, 6.7-, and 6-fold increased secreted leptin antigen, respectively, at 72 hours (P&lt;0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Neurologically symptomatic patients overexpress leptin <z:chebi fb="2" ids="33699">mRNA</z:chebi> and synthesize leptin protein in carotid plaque macrophages and smooth muscle cells </plain></SENT>
<SENT sid="11" pm="."><plain>Local leptin induction, presumably by TNF-α, could exert paracrine or autocrine effects, thereby contributing to the pathogenesis of lesion instability </plain></SENT>
<SENT sid="12" pm="."><plain>CLINICAL TRIAL REGISTRATION: URL: www.Clinicaltrials.gov </plain></SENT>
<SENT sid="13" pm="."><plain>Unique identifier: NCT00449306 </plain></SENT>
</text></document>